Login or sign up
For business

Genapsys, inc.

3.9Β· 10 reviews
Average ratingAverage
3.9/ 5

Based on 10 reviews

520%
450%
330%
20%
10%
Ask AI

Ask Trustburn about Genapsys, inc.

Based on 10 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Ce6979 Hill
Reviews 1

I recently had an exceptional experience with a biotech company whose products and services truly exceeded my expectations. The innovative technology and comprehensive solutions offered by the company have helped me achieve significant progress in my research endeavors. The user-friendly interface of their platform made it easy for me to analyze complex genetic data, saving me time and enhancing the efficiency of my work. Additionally, the company's commitment to advancing scientific research and empowering researchers like myself is truly commendable. The support team was also highly responsive and provided valuable assistance whenever needed. I highly recommend this company to anyone looking to streamline their genetic analysis workflows and make meaningful strides in their research.

Anantha Rao
Reviews 1

I recently had the opportunity to work with Genapsys, inc., and I must say that my experience was excellent. The team was extremely knowledgeable and provided outstanding service. The technology they offer is top-notch, and their attention to detail is unmatched. I would highly recommend Genapsys, inc. to anyone in need of their services.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website β€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Genapsys, inc.

Genapsys exists to transform the human condition by building a scalable, affordable genomic sequencing ecosystem that supports research and diagnostics. Learn more here.

Genapsys, Inc. is a company that is dedicated to transforming the human condition by building a scalable and affordable genomic sequencing ecosystem that supports research and diagnostics. The company was founded in 2010 by Dr. Hesaam Esfandyarpour, who serves as the CEO of Genapsys.

The mission of Genapsys is to make genomic sequencing accessible to everyone, regardless of their location or financial situation. The company believes that this will lead to breakthroughs in medical research and personalized medicine, ultimately improving the lives of people around the world.

One of the key advantages of Genapsys' technology is its scalability. Traditional genomic sequencing technologies are expensive and time-consuming, making it difficult for researchers and clinicians to sequence large numbers of samples quickly and cost-effectively. However, Genapsys' proprietary technology allows for high-throughput sequencing at a fraction of the cost and time required by traditional methods.

Another advantage of Genapsys' technology is its affordability. By reducing the cost per sample, Genapsys makes it possible for more researchers and clinicians to access genomic sequencing technology than ever before. This has important implications for medical research, as well as for clinical applications such as cancer diagnosis and treatment.

Genapsys has already made significant strides in advancing genomics research through partnerships with leading academic institutions such as Harvard Medical School, Stanford University School of Medicine, UC Berkeley's Innovative Genomics Institute (IGI), among others.

In addition to its work in genomics research, Genapsys also offers diagnostic services through its CLIA-certified laboratory division called "GenapSys Clinical Services". This division provides clinical-grade testing services using next-generation sequencing (NGS) technologies across various disease areas including oncology (cancer), reproductive health (prenatal screening), infectious diseases among others.

The company's commitment towards innovation has been recognized with numerous awards including being named one among Fast Company’s Most Innovative Companies 2021 list under Biotech category; Frost & Sullivan’s 2020 North American New Product Innovation Award; CNBC Disruptor 50 List; Red Herring Top 100 North America award winner among others

In conclusion, if you're looking for an innovative genomics company that can help transform your research or diagnostic needs then look no further than GenapSys Inc! With their cutting-edge technology platform coupled with their commitment towards making genomics accessible & affordable they are poised to revolutionize how we approach healthcare today!

Address
200 cardinal way
Categories
Biotechnology